CUBT (Curative Biotechnology) Other Current Receivables: $0.00 Mil (As of Mar. 2023)


What is Curative Biotechnology Other Current Receivables?

Curative Biotechnology CUBT +5.00% Other Current Receivables is $0.00 Mil as of Mar. 2023.

Curative Biotechnology's Other Current Receivables for the quarter that ended in Mar. 2023 was $0.00 Mil.

Curative Biotechnology's annual Other Current Receivables declined from Dec. 2020 ($0.07 Mil) to Dec. 2021 ($0.03 Mil) and declined from Dec. 2021 ($0.03 Mil) to Dec. 2022 ($0.00 Mil).

Curative Biotechnology Other Current Receivables Related Terms

Curative Biotechnology Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Other Current Receivables Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Receivables
Get a 7-Day Free Trial 0.00 0.00 0.07 0.03 0.00

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Curative Biotechnology Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Curative Biotechnology (CUBT) has a Other Current Receivables of $0.00 Mil as of Mar. 2023. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Curative Biotechnology and its competitors.
Is Curative Biotechnology's Other Current Receivables too high?
Curative Biotechnology's current Other Current Receivables is $0.00 Mil.
How does Curative Biotechnology's Other Current Receivables compare to ORGS and SNSE?
Curative Biotechnology's Other Current Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Curative Biotechnology and its competitors. Curative Biotechnology's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Other Current Receivables is $0.00 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.